As it turns out, that might have spared Walgreens an even more painful reckoning than the one it now faces.

事实证明，这可能使沃尔格林避免面临比现在所处的更艰难的局面。

Walgreens' rivals, such as CVS, wisely kept quiet.

Walgreens 的竞争对手，如 CVS，明智地保持沉默。

Walgreens's troubles reflect a power shift that's reshaping the entire prescription-drug industry, from the companies that research and manufacture pills to the insurance companies that pay for them.

沃尔格林面临的问题反映出一种权力转移，它正在重塑整个处方药行业，使其从研究和生产药品的公司转型到为药品买单的保险公司。

These days, nobody cares whether you have Walgreens in the network, says Michael Rea, founder of Rx Savings Solutions, which has an app that helps patients find the best prices.

药品比价公司RX Savings Solutions的创始人迈克尔·雷表示，如今，“没人关心你的销售网络中是否包含沃尔格林。”RX Savings Solutions有一个应用，可以帮助患者找到最优惠的药品价格。